ConductScience.org, home

Paper35455366

Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac® in Preventing Recurrent Meningitis Epidemics in Sub-Saharan Africa.

Viviani S. Vaccines (Basel), 2022. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac® in Preventing Recurrent Meningitis Epidemics in Sub-Saharan Africa. Papers, record 35455366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35455366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac® in Preventing Recurrent Meningitis Epidemics in Sub-Saharan Africa.
PubMed
Journal
Vaccines (Basel)
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.81
iCite
Revised in PubMed
2024-08-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Viviani SSimonettahttps://orcid.org/0000-0002-3652-5082

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126553682A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians.Clin Infect Dis2015https://conductscience.org/library/papers/26553682PubMed
224035220Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].Lancet2014https://conductscience.org/library/papers/24035220PubMed
325702330Meningococcal A conjugate vaccine: updated guidance, February 2015.Wkly Epidemiol Rec2015https://conductscience.org/library/papers/25702330PubMed
429116892Lessons from the Meningitis Vaccine Project.Viral Immunol2018https://conductscience.org/library/papers/29116892PubMed
5417754Prevention of secondary cases of meningococcal disease in household contacts by vaccination.Br Med J1978https://conductscience.org/library/papers/417754PubMed
64211056A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.Bull World Health Organ1973https://conductscience.org/library/papers/4211056PubMed
719360984Outbreak news. Meningococcal disease, African meningitis belt.Wkly Epidemiol Rec2009https://conductscience.org/library/papers/19360984PubMed
810756001
Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates.
Clin Microbiol Rev2000https://conductscience.org/library/papers/10756001PubMed
934077644Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers.N Engl J Med2021https://conductscience.org/library/papers/34077644PubMed
1034451392Evaluation of Critical Quality Attributes of a Pentavalent (A, C, Y, W, X) Meningococcal Conjugate Vaccine for Global Use.Pathogens2021https://conductscience.org/library/papers/34451392PubMed
1117521780The Meningitis Vaccine Project.Vaccine2007https://conductscience.org/library/papers/17521780PubMed
123934317Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies.J Exp Med1985https://conductscience.org/library/papers/3934317PubMed
13572789[Controlled tests of anti-meningococcal polysaccharide A vaccine in the African Sahel area (Upper Volta and Mali) ].Dev Biol Stand1978https://conductscience.org/library/papers/572789PubMed
143130424Meningococcal carriage, meningococcal disease and vaccination.J Infect1988https://conductscience.org/library/papers/3130424PubMed
1519842972Costs for households and community perception of meningitis epidemics in burkina faso.Clin Infect Dis2009https://conductscience.org/library/papers/19842972PubMed
1610427935Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96.Bull World Health Organ1999https://conductscience.org/library/papers/10427935PubMed
1711078484Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.J Infect Dis2001https://conductscience.org/library/papers/11078484PubMed
1810228085Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.J Infect Dis1999https://conductscience.org/library/papers/10228085PubMed
194977283Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.J Exp Med1969https://conductscience.org/library/papers/4977283PubMed
2031671449Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.J Infect Dis2019https://conductscience.org/library/papers/31671449PubMed

See all 61 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42605878Meningitis Vaccine Delivery Strategies and Their Health Impact in Africa: A Scoping Review to Inform the Introduction of New Vaccines.Inquiry2026https://conductscience.org/library/papers/42605878PubMed
42347623
Vaccination Against Serogroup B Meningococcal Disease: Current Status and Future Perspectives-A Consensus Document of the World Association for Infectious Diseases and Immunological Disorders (WAidid).
Vaccines (Basel)2026https://conductscience.org/library/papers/42347623PubMed
42244090Human Organoids as a Novel Tool for Vaccine Study.Adv Healthc Mater2026https://conductscience.org/library/papers/42244090PubMed
41667987Trends in bacterial meningitis in Guinea in the post-MenAfriVac era: a retrospective cross-sectional study (2021-2024).BMC Infect Dis2026https://conductscience.org/library/papers/41667987PubMed
38625118Monophosphoryl Lipid A-based Adjuvant to Promote the Immunogenicity of Multivalent Meningococcal Polysaccharide Conjugate Vaccines.Immunohorizons2024https://conductscience.org/library/papers/38625118PubMed
36978869High Concentration of Protein Oxidation Biomarker O-Tyr/Phe Predicts Better Outcome in Childhood Bacterial Meningitis.Antioxidants (Basel)2023https://conductscience.org/library/papers/36978869PubMed
36852982Genetic, Functional, and Immunogenic Analyses of the O-Linked Protein Glycosylation System in Neisseria meningitidis Serogroup A ST-7 Isolates.J Bacteriol2023https://conductscience.org/library/papers/36852982PubMed
36273639Meningococcal disease in North America: Updates from the Global Meningococcal Initiative.J Infect2022https://conductscience.org/library/papers/36273639PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35455366

GET https://conductscience.org/api/papers/v1/35455366/references?page=2